Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin J S Dyer

Showing results (1-10 of 166) with videos related to

Pageof 17
Sort By:
International Journal of Hematology|May 31, 2003
The pathogenetic role of oncogenes deregulated by chromosomal translocation in B-cell malignanciesMartin J S Dyer
Therapeutic Advances in Hematology|April 23, 2013
Safety and efficacy of ofatumumab in patients with fludarabine and alemtuzumab refractory chronic lymphocytic leukaemiaMartin J S Dyer
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 3, 2003
Bioweapons of tumor mass destruction?Martin J S Dyer
Methods in Molecular Biology (Clifton, N.J.)|January 9, 2013
The detection of chromosomal translocations involving the immunoglobulin loci in B-cell malignanciesMartin J S Dyer
British Journal of Haematology|September 20, 2011
Bilateral subdural hygromas following intrathecal methotrexatePadmaja Lokireddy, Martin J S Dyer
The Lancet. Haematology|March 3, 2022
Chronic lymphocytic leukaemia therapy: is less more?Harriet S Walter, Martin J S Dyer
Blood|May 2, 2024
BCL2 inhibition: back to the future!Martin J S Dyer, Harriet S Walter
British Journal of Haematology|April 23, 2014
Breaking good: the inexorable rise of BTK inhibitors in the treatment of chronic lymphocytic leukaemiaClaire V Hutchinson, Martin J S Dyer
The New England Journal of Medicine|January 17, 2014
Efficacy of vemurafenib in hairy-cell leukemiaJesvin Samuel, Salvador Macip, Martin J S Dyer
Trends in Cell Biology|October 22, 2010
pH regulation and beyond: unanticipated functions for the voltage-gated proton channel, HVCN1Melania Capasso, Thomas E DeCoursey, Martin J S Dyer
Pageof 17

Showing results (1-10 of 166) with videos related to

Sort By:
Pageof 17
International Journal of Hematology|May 31, 2003
The pathogenetic role of oncogenes deregulated by chromosomal translocation in B-cell malignanciesMartin J S Dyer
Therapeutic Advances in Hematology|April 23, 2013
Safety and efficacy of ofatumumab in patients with fludarabine and alemtuzumab refractory chronic lymphocytic leukaemiaMartin J S Dyer
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 3, 2003
Bioweapons of tumor mass destruction?Martin J S Dyer
Methods in Molecular Biology (Clifton, N.J.)|January 9, 2013
The detection of chromosomal translocations involving the immunoglobulin loci in B-cell malignanciesMartin J S Dyer
British Journal of Haematology|September 20, 2011
Bilateral subdural hygromas following intrathecal methotrexatePadmaja Lokireddy, Martin J S Dyer
The Lancet. Haematology|March 3, 2022
Chronic lymphocytic leukaemia therapy: is less more?Harriet S Walter, Martin J S Dyer
Blood|May 2, 2024
BCL2 inhibition: back to the future!Martin J S Dyer, Harriet S Walter
British Journal of Haematology|April 23, 2014
Breaking good: the inexorable rise of BTK inhibitors in the treatment of chronic lymphocytic leukaemiaClaire V Hutchinson, Martin J S Dyer
The New England Journal of Medicine|January 17, 2014
Efficacy of vemurafenib in hairy-cell leukemiaJesvin Samuel, Salvador Macip, Martin J S Dyer
Trends in Cell Biology|October 22, 2010
pH regulation and beyond: unanticipated functions for the voltage-gated proton channel, HVCN1Melania Capasso, Thomas E DeCoursey, Martin J S Dyer
Pageof 17